N4BP1 and neoplasm: Insofar as they show exaggerated innate immune responses but are not overtly suffering from autoimmunity or inflammatory disease, pharmacologic inhibition of N4BP1 might have useful applications, for example, in the improvement of vaccine responses or as an adjunct to checkpoint inhibitors in the treatment of neoplastic diseases.